245 related articles for article (PubMed ID: 29733510)
1. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh N; Webster RD; Gutierrez Barrera AM; Lin H; Kuerer HM; Litton JK; Bedrosian I; Arun BK
Cancer Med; 2018 Jun; 7(6):2718-2726. PubMed ID: 29733510
[TBL] [Abstract][Full Text] [Related]
2. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
[TBL] [Abstract][Full Text] [Related]
3. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
4. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
[TBL] [Abstract][Full Text] [Related]
5. Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
Pederson HJ; Gopalakrishnan D; Noss R; Yanda C; Eng C; Grobmyer SR
J Am Coll Surg; 2018 Apr; 226(4):560-565. PubMed ID: 29360614
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
[TBL] [Abstract][Full Text] [Related]
7. Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer.
Ro V; McGuinness JE; Guo B; Trivedi MS; Jones T; Chung WK; Rao R; Levinson E; Koval C; Russo D; Chilton I; Kukafka R; Crew KD
JCO Oncol Pract; 2022 Apr; 18(4):e472-e483. PubMed ID: 34705516
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.
Fasano GA; Bayard S; Chen Y; Marti J; Simmons R; Swistel A; Bensenhaver J; Davis M; Newman L
Ann Surg Oncol; 2023 Aug; 30(8):4648-4656. PubMed ID: 36681737
[TBL] [Abstract][Full Text] [Related]
9. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Murphy BL; Yi M; Arun BK; Gutierrez Barrera AM; Bedrosian I
Ann Surg Oncol; 2020 Nov; 27(12):4613-4621. PubMed ID: 32720048
[TBL] [Abstract][Full Text] [Related]
10. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
[TBL] [Abstract][Full Text] [Related]
11. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
Chang J; Seng S; Yoo J; Equivel P; Lum SS
Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
[TBL] [Abstract][Full Text] [Related]
12. Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in
Makhnoon S; Gutierrez Barrera AM; Bassett R; Afrough A; Bedrosian I; Arun BK
Breast J; 2022; 2022():1447545. PubMed ID: 36685664
[TBL] [Abstract][Full Text] [Related]
13. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Grindedal EM; Heramb C; Karsrud I; Ariansen SL; Mæhle L; Undlien DE; Norum J; Schlichting E
BMC Cancer; 2017 Jun; 17(1):438. PubMed ID: 28637432
[TBL] [Abstract][Full Text] [Related]
14. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions.
Murray ML; Cerrato F; Bennett RL; Jarvik GP
Genet Med; 2011 Dec; 13(12):998-1005. PubMed ID: 21811163
[TBL] [Abstract][Full Text] [Related]
16. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
Zhang JQ; Dos Anjos CH; Sevilimedu V; Crown A; Amoroso KA; Pilewskie ML; Robson ME; Gemignani ML
Ann Surg Oncol; 2023 Nov; 30(12):6990-6999. PubMed ID: 37661222
[TBL] [Abstract][Full Text] [Related]
17. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
[TBL] [Abstract][Full Text] [Related]
18. What made her give up her breasts: a qualitative study on decisional considerations for contralateral prophylactic mastectomy among breast cancer survivors undergoing BRCA1/2 genetic testing.
Kwong A; Chu AT
Asian Pac J Cancer Prev; 2012; 13(5):2241-7. PubMed ID: 22901201
[TBL] [Abstract][Full Text] [Related]
19. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
20. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
